Back
LakeShore Biopharma Vs. CASI Pharmaceuticals Industry Stock Comparison
Sell
27
LSB
LakeShore Biopharma
Last Price:
3.07
Seasonality Move:
-5.51%
Buy
55
CASI
CASI Pharmaceuticals
Last Price:
5.54
Seasonality Move:
7.6%
Sell
27
LakeShore Biopharma (LSB)
is a Sell
Is LakeShore Biopharma a Buy, Sell or Hold?
- The current LakeShore Biopharma [LSB] share price is $3.10. The Score for LSB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- LSB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
CASI Pharmaceuticals (CASI)
is a Buy
Is CASI Pharmaceuticals a Buy, Sell or Hold?
- The current CASI Pharmaceuticals [CASI] share price is $5.55. The Score for CASI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CASI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LSB Stock Price Chart
What is LakeShore Biopharma's stock price today?
-
The LakeShore Biopharma share price today is $3.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LSB is experiencing buying pressure, which is a positive indicator for future bullish movement.
CASI Stock Price Chart
What is CASI Pharmaceuticals's stock price today?
-
The CASI Pharmaceuticals share price today is $5.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing slight buying pressure.
LSB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 48.45 | Sell |
| Chaikin Money Flow: | 11243 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.32 - 3.52) | Buy |
| Bollinger Bands (100): | (-0.08 - 2.8) | Buy |
CASI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 43.53 | Sell |
| Chaikin Money Flow: | 7924 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.53 - 6.07) | Sell |
| Bollinger Bands (100): | (5.45 - 6.83) | Sell |
LSB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.44 | Buy |
| 20-day SMA: | 2.7 | Buy |
| 50-day SMA: | 2.25 | Buy |
| 200-day SMA: | 1.03 | Buy |
| 8-day EMA: | 2.64 | Buy |
| 20-day EMA: | 2.65 | Buy |
| 50-day EMA: | 2.29 | Buy |
| 200-day EMA: | 1.47 | Buy |
CASI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.71 | Sell |
| 20-day SMA: | 5.79 | Sell |
| 50-day SMA: | 6.05 | Sell |
| 200-day SMA: | 5 | Buy |
| 8-day EMA: | 5.68 | Sell |
| 20-day EMA: | 5.78 | Sell |
| 50-day EMA: | 5.9 | Sell |
| 200-day EMA: | 5.27 | Buy |
LakeShore Biopharma Earnings Growth & LSB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.21 per share.
CASI Pharmaceuticals Earnings Growth & CASI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
LakeShore Biopharma Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CASI Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||